ADAGIO MEDICAL HOLDINGS, INC. Cost of Revenue
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Cost of Revenue of $684.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-11
- ADAGIO MEDICAL HOLDINGS, INC. cost of revenue for the quarter ending 2025-12-31 was $58.00K.
- ADAGIO MEDICAL HOLDINGS, INC. cost of revenue for the quarter ending 2025-09-30 was $31.00K.
- ADAGIO MEDICAL HOLDINGS, INC. cost of revenue for the quarter ending 2025-06-30 was $342.00K, a 49.85% decline year-over-year.
- ADAGIO MEDICAL HOLDINGS, INC. cost of revenue for the quarter ending 2025-03-31 was $253.00K, a 53.32% decline year-over-year.
- ADAGIO MEDICAL HOLDINGS, INC. cost of revenue for fiscal 2025 was $684.00K.
- ADAGIO MEDICAL HOLDINGS, INC. cost of revenue for fiscal 2023 was $1.31M.
| Period end | Cost of Revenue 1 month | Cost of Revenue 2 month | Cost of Revenue 3 month | Cost of Revenue 5 month | Cost of Revenue 6 month | Cost of Revenue 7 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $89.00K derived: sum of 2 quarters · filed 2026-03-27 | $431.00K derived: sum of 3 quarters · filed 2026-08-11 | $684.00K 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | $31.00K 10-Q · filed 2025-11-12 | $373.00K derived: sum of 2 quarters · filed 2026-08-11 | $626.00K 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | $342.00K 10-Q · filed 2026-08-11 | $595.00K 10-Q · filed 2026-08-11 | ||||||
| 2025-03-31 | $253.00K 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | $1.94M 10-K · filed 2026-03-27 | |||||||
| 2024-09-30 | $414.00K 10-Q · filed 2025-11-12 | |||||||
| 2024-07-30 | $157.00K 10-Q · filed 2025-11-12 | $1.38M 10-K · filed 2026-03-27 | ||||||
| 2024-06-30 | $682.00K 10-Q · filed 2025-08-14 | $1.22M 10-Q · filed 2025-08-14 | $1.56M derived: sum of 3 quarters · filed 2025-08-14 | $1.81M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $542.00K 10-Q · filed 2025-05-15 | $876.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.13M derived: sum of 3 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $587.00K derived: sum of 2 quarters · filed 2025-03-27 | $1.31M 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | $253.00K 10-Q · filed 2024-11-14 | $972.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |